A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.
The researchers hoped that, when used as a vaccine, the modified mRNA would produce spike proteins on cell surfaces and on the surfaces of released eVLPs, stimulating antibody production above and ...
The 25,000-subject study is testing a nucleoside-modified mRNA (modRNA), quadrivalent vaccine that is targeted against four strains of the flu virus that the World Health Organization (WHO ...
Moderna gained access to valuable patents from the University of Pennsylvania covering modified mRNA technology through a nonexclusive license (via mRNA RiboTherapeutics and its affiliate ...
Penn Engineers have modified lipid nanoparticles (LNPs) -; the revolutionary technology behind the COVID-19 mRNA vaccines -; to not only cross the blood-brain barrier (BBB) but also to target ...